hsa-mir-588: Hsa-mir-588 is a microRNA that has been found to have binding sites in circN4BP2L2 and is associated with various biological processes and diseases, including lung squamous cell cancer, COVID-19, MI, and glioma [PMC8721970] [PMC10067640] [PMC7700842] [PMC5041942]. It has been identified as a potential regulator of GRN in lung squamous cell cancer, affecting cell migration and invasion [PMC8721970]. Hsa-mir-588 has also been found to target ACE2 in COVID-19 and MI, suggesting its involvement in the pathogenesis of these diseases [PMC7700842]. In glioma, hsa-mir-588 is associated with the regulation of dysfunctional pathways and malignant progression [PMC5041942]. Additionally, hsa-mir-588 has been implicated as a tumor suppressor gene in colon cancer through its binding to SUCLG2 and SUCLG2P2 [PMC8475515]. It has also been identified as one of the key miRNAs associated with a lower overall survival rate in various cancers including breast cancer [PMC8544338]. Furthermore, hsa-mir-588 has shown negative correlations with CYB561 expression in breast cancer, suggesting its potential role as an inhibitor of breast cancer progression or predictor of better prognosis [PMC8722309]. Overall, hsa-mir-588 is a versatile microRNA that plays important roles in various biological processes and diseases.